Brief: Getinge Keeps 2023 Outlook Unchanged

Getinge publ AB

23/10/2023 07:09

Oct 23 (Reuters) - Getinge AB  GETIb.ST :
    * INTERIM REPORT JULY - SEPTEMBER 2023: HIGHER SALES,
GRADUALLY
STRENGTHENED MARGINS AND STABLE CASH FLOWS
    *  MOST OF OPERATIONS IN ACUTE CARE THERAPIES PERFORMED
POSITIVELY
    * SALES IN LIFE SCIENCE WERE UNCHANGED AND SURGICAL
WORKFLOWS GREW
IN ALL PRODUCT CATEGORIES AND REGIONS
    * ORDER INTAKE DECLINED ORGANICALLY BY A TOTAL OF 1.9% IN
QUARTER,
WHICH WAS EXCLUSIVELY LINKED TO ACUTE CARE THERAPIES
    * UNCHANGED OUTLOOK
    * OUTLOOK 2023: NET SALES FOR 2023 ARE EXPECTED TO INCREASE
BY
2-5% ORGANICALLY. (UNCHANGED OUTLOOK)
    * CONTINUING LOW DEMAND IN PRODUCTS FOR DEVELOPMENT AND
PRODUCTION
OF BIOPHARMACEUTICALS, WAGE INFLATION, COSTS FOR FIELD
CORRECTIONS IN CARDIAC ASSIST, PACKAGING PROBLEMS IN
CARDIOPULMONARY NEGATIVELY IMPACTED EARNINGS

Source text for Eikon:  ID:nWkr8TQ5vd 
Further company coverage:  GETIb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))